Aclaris Therapeutics to Present at Upcoming Investor Conferences in June

MALVERN, Pa., May 31, 2016 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (NASDAQ: ACRS), a clinical-stage specialty pharmaceutical company, today announced that Dr. Neal Walker, President & Chief Executive Officer, will present at three upcoming investor conferences in June.

Jefferies 2016 Healthcare ConferenceJune 8, 2016, 3:00 p.m. EDTGrand Hyatt, New York City

William Blair’s 35th Annual Growth Stock Conference June 15, 2016, 9:20 a.m. CDTFour Seasons Hotel, Chicago

JMP Securities Life Sciences Conference June 22, 2016, 11:30 a.m. EDTThe St. Regis, New York City

A live audio webcast of the Aclaris presentations may be accessed by visiting the “Investors” section of the Company’s website at www.aclaristx.com. A replay of the webcasts will be archived on the Aclaris website for 14 days following the presentation dates.

About AclarisAclaris Therapeutics, Inc. is a clinical-stage specialty pharmaceutical company focused on identifying, developing, and commercializing innovative and differentiated drugs to address significant unmet needs in dermatology.  Aclaris Therapeutics, Inc. is based in Malvern, Pennsylvania and more information can be found by visiting the company’s website at www.aclaristx.com.

Contact: 
Aclaris Contact
Frank Ruffo
Chief Financial Officer
484-324-7933
[email protected]

Investor Contact
Patricia L. Bank
Westwicke Partners
Managing Director
415-513-1284
[email protected]

Media Contact
Mike Beyer
Sam Brown, Inc.
312-961-2502
[email protected]

You May Also Be Interested In

• SURF'S UP FOR THE WORLD'S PAW-SOME-EST COMPETITORS!
• 7 Best Cryptos in 2026 to Watch: Apeing’s Crypto Presale Making Headlines With Over $80K Raised
• Sean Kirtz and Lady Hammers Earn 3rd Place at Midwest Nationals